Trial Profile
Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes. A Randomized Clinical Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Jan 2024
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary) ; Insulin; Liraglutide
- Indications Type 1 diabetes mellitus
- Focus Proof of concept; Therapeutic Use
- 11 Jun 2019 Results evaluating the increase in both plasma GLP-1 and GLP-2 concentrations the presented at the 79th Annual Scientific Sessions of the American Diabetes Association.
- 13 Aug 2015 New trial record